ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,222,000 | +35.1% | 3,914,938 | +45.3% | 8.75% | +17.6% |
| Q2 2021 | $14,226,000 | -13.3% | 2,694,295 | -21.2% | 7.44% | -16.1% |
| Q1 2021 | $16,408,000 | +368.7% | 3,418,279 | +322.8% | 8.86% | +230.7% |
| Q4 2020 | $3,501,000 | +29.2% | 808,431 | +23.0% | 2.68% | -4.9% |
| Q3 2020 | $2,709,000 | +39.6% | 657,467 | -13.2% | 2.82% | -25.0% |
| Q2 2020 | $1,940,000 | -42.3% | 757,704 | -34.8% | 3.76% | +5.7% |
| Q1 2020 | $3,361,000 | -60.4% | 1,162,876 | -48.1% | 3.55% | -40.0% |
| Q4 2019 | $8,494,000 | +121.1% | 2,241,239 | +198.4% | 5.92% | +58.8% |
| Q3 2019 | $3,841,000 | -56.5% | 751,012 | -47.2% | 3.73% | -38.7% |
| Q2 2019 | $8,826,000 | +26.1% | 1,423,578 | +44.6% | 6.08% | +50.9% |
| Q1 2019 | $6,999,000 | – | 984,329 | – | 4.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
| Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
| Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
| Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
| DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
| Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
| EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
| DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |